Pharmaceutical Executive
Trinity Life Sciences’ President and CEO, Leslie Orne, authored an article in Pharmaceutical Executive. To learn about strategies for success in an evolving commercial landscape, read the article. Read Now…
MedCity Moves Podcast
Hear from Leslie Orne, President and CEO of Trinity Life Sciences, as she shares her thoughts on the current biotech renaissance and AI innovation in the life sciences space in an interview on the MedCity News podcast Healthcare Moves. Listen Now…
Pharmaceutical Commerce Magazine
Trinity experts were featured in Pharmaceutical Commerce Magazine In this article written by Suzanne Shelley entitled “Disruptive Factors Shape RA Landscape” for Pharmaceutical Commerce Magazine, Akshay Mehta, Principal, Strategic Advisory, Trinity Life Sciences, and Mary Lynn Kelley, Vice President, Patient Support Services, TGaS Advisors (a division of Trinity Life Sciences), comment on the new technologies and biosimilar entrants that are adding complexity to the rheumatoid arthritis landscape, and share their perspectives on what life science executives should consider in their commercial decision-making…
ISPOR's Value & Outcomes Spotlight
Trinity experts Maximilian Hunt, BS, Ismail Ismailoglu, PhD, Grace Mock, BA, and Helen Amata, MPH have been featured in ISPOR’s Value & Outcomes Spotlight Read Now…
Fierce Pharma
Trinity’s recent white paper, titled Empowering the Next-Generation Launch Model, was featured in a recent article by Fierce Pharma. Read now…
Formulary Watch
Trinity’s recent white paper, titled Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR, was featured in a recent article by Formulary Watch. Read now…
Fierce Biotech
Trinity’s recent white paper, titled Diversity in Clinical Trials Participation: A Life Sciences Perspective, was featured in a recent article by Fierce Biotech. Read now…
Fierce Pharma
Third-party tracking cookies aren’t as important to pharma as they are to consumer marketers. Automakers, for instance, can follow online car shoppers, putting targeted digital ads in buyers’ paths as they move across the internet hoping for a sale. However, privacy policies on most sites nix drugmakers use of third-party cookies to serve ads to people looking for diabetes or cancer information. Still, tracking data does matter in pharma—especially when it comes to measurement and analytics. The good news for pharma…
PM360
Read in PM360. Sue Lipinski, TGaS® Advisors, a division of Trinity At an individual brand level, it’s highly unlikely that social media platform activity will decrease based upon the social media scandals from 2018. Most of the marketing efforts that TGaS benchmarks are showing that brands leverage these platforms intelligently and with great consideration. Now, if their key driver analysis (KDA) or ROI analysis indicates little to no value from social media, then you will see a decrease. However, at…
